JP2024547057A5 - - Google Patents
Info
- Publication number
- JP2024547057A5 JP2024547057A5 JP2024536988A JP2024536988A JP2024547057A5 JP 2024547057 A5 JP2024547057 A5 JP 2024547057A5 JP 2024536988 A JP2024536988 A JP 2024536988A JP 2024536988 A JP2024536988 A JP 2024536988A JP 2024547057 A5 JP2024547057 A5 JP 2024547057A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- circular rna
- circular
- cells
- myc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163291645P | 2021-12-20 | 2021-12-20 | |
| US63/291,645 | 2021-12-20 | ||
| PCT/US2022/081898 WO2023122517A2 (en) | 2021-12-20 | 2022-12-19 | Compositions and methods for cellular reprogramming using circular rna |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024547057A JP2024547057A (ja) | 2024-12-26 |
| JP2024547057A5 true JP2024547057A5 (https=) | 2026-01-05 |
Family
ID=86903667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024536988A Pending JP2024547057A (ja) | 2021-12-20 | 2022-12-19 | 環状ｒｎａを使用した細胞の再プログラム化のための組成物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240327799A1 (https=) |
| EP (1) | EP4453205A4 (https=) |
| JP (1) | JP2024547057A (https=) |
| KR (1) | KR20240123826A (https=) |
| CN (1) | CN118574930A (https=) |
| AU (1) | AU2022420484A1 (https=) |
| CA (1) | CA3240645A1 (https=) |
| IL (1) | IL313604A (https=) |
| TW (1) | TW202330907A (https=) |
| WO (1) | WO2023122517A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025106897A1 (en) * | 2023-11-16 | 2025-05-22 | Colossal Biosciences Inc. | Methods and compositions for creating induced pluripotent stem cells |
| WO2025240429A1 (en) * | 2024-05-13 | 2025-11-20 | Colossal Biosciences Inc. | Methods and compositions for creating elephant induced pluripotent stem cells |
| CN118638781B (zh) * | 2024-05-27 | 2025-05-16 | 毕昇(北京)生物科技有限公司 | 使用环状RNA和microRNA进行细胞重编程的组合物和方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8496941B2 (en) * | 2009-06-03 | 2013-07-30 | National Institute Of Advanced Industrial Science And Technology | Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same |
| US20120301438A1 (en) * | 2009-09-14 | 2012-11-29 | The Johns Hopkins University | Reprogramming Blood Cells to Pluripotent and Multipotent Stem Cells |
| PL2852671T3 (pl) * | 2012-05-21 | 2019-06-28 | The Regents Of The University Of California | Wytwarzanie ludzkich komórek ips z użyciem syntetycznego samoreplikującego się rna |
| BR112021023411A2 (pt) * | 2019-05-22 | 2022-02-01 | Massachusetts Inst Technology | Composições e métodos de rna circular |
| CA3217001A1 (en) * | 2021-04-27 | 2022-11-03 | Matthew Angel | Circular rna |
| US20230042860A1 (en) * | 2021-07-15 | 2023-02-09 | Turn Biotechnologies, Inc. | Polycistronic expression vectors |
-
2022
- 2022-12-19 JP JP2024536988A patent/JP2024547057A/ja active Pending
- 2022-12-19 AU AU2022420484A patent/AU2022420484A1/en active Pending
- 2022-12-19 KR KR1020247023505A patent/KR20240123826A/ko active Pending
- 2022-12-19 IL IL313604A patent/IL313604A/en unknown
- 2022-12-19 CA CA3240645A patent/CA3240645A1/en active Pending
- 2022-12-19 CN CN202280083120.5A patent/CN118574930A/zh active Pending
- 2022-12-19 EP EP22912615.6A patent/EP4453205A4/en active Pending
- 2022-12-19 WO PCT/US2022/081898 patent/WO2023122517A2/en not_active Ceased
- 2022-12-20 TW TW111149043A patent/TW202330907A/zh unknown
-
2024
- 2024-06-17 US US18/745,761 patent/US20240327799A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024547057A5 (https=) | ||
| JP7153992B2 (ja) | Ｒｎａ誘導性遺伝子制御および編集のための直交性ｃａｓ９タンパク質 | |
| JP6940117B2 (ja) | オンターゲットおよびオフターゲットの多標的システムを用いた標的特異的ヌクレアーゼをスクリーニングするための方法およびその利用 | |
| ES2865275T3 (es) | Células inmunocompatibles creadas por edición mediada por nucleasas, de genes que codifican HLA | |
| JP7059468B2 (ja) | 多重ゲノム編集 | |
| AU2015334469B2 (en) | Permanent epigenetic gene silencing | |
| CA3228222A1 (en) | Class ii, type v crispr systems | |
| US20170175140A1 (en) | Methods for using a 5'-exonuclease to increase homologous recombination in eukaryotic cells | |
| EP4284932A1 (en) | Gene silencing | |
| JP2019524140A5 (https=) | ||
| JP2017517256A (ja) | 遺伝子配列を編集する方法 | |
| WO2021146222A1 (en) | Modification of blood type antigens | |
| US20240318165A1 (en) | Type i-b crispr-associated transposase systems | |
| US20250304934A1 (en) | Reprogrammable fanzor polynucleotides and uses thereof | |
| US20240123088A1 (en) | USE OF A SPLIT dCAS FUSION PROTEIN SYSTEM FOR EPIGENETIC EDITING | |
| US20220298501A1 (en) | Crispr-associated mu transposase systems | |
| Schumann et al. | The impact of transposable element activity on therapeutically relevant human stem cells | |
| Zhao et al. | Recombinase-mediated reprogramming and dystrophin gene addition in mdx mouse induced pluripotent stem cells | |
| JP2023526007A5 (https=) | ||
| JP2024511621A5 (https=) | ||
| Wang et al. | Measles vector as a multigene delivery platform facilitating iPSC reprogramming | |
| KR20200066748A (ko) | 바이러스 벡터, 세포 및 작제물 | |
| Papapetrou | Gene and cell therapy for β-thalassemia and sickle cell disease with induced pluripotent stem cells (iPSCs): the next frontier | |
| JP2010088332A (ja) | 複数の遺伝子発現を行うための発現ベクター | |
| JP2025501617A (ja) | 相同組換え及びインテグラーゼ媒介性組換えによりヒト人工多能性幹細胞を製造する方法 |